FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition containing as an active ingredient an optically active compound presented by formula:
wherein R1 represents a halogen atom or C1-C3alkyloxy; R2 represents C1-C8alkyl; R3 represents C1-C8alkyl; each R4 and R5 independently represents a fluorine atom or a chlorine atom; R6 represents C1-C3alkyl or C1-C3alkyloxy; * specifies that a starred carbon atom is an asymmetric carbon atom, its pharmaceutically acceptable salt or its solvate which possess activity of a thrombopoietin receptor agonist.
EFFECT: preparing the new pharmaceutical composition which possess activity of a thrombopoietin receptor agonist.
12 cl, 5 tbl, 6 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DICARBOXYLIC ACID COMPOUND | 2014 |
|
RU2662817C2 |
| NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
| HETEROCYCLIC COMPOUNDS AND METHODS OF APPLICATION | 2009 |
|
RU2525116C2 |
| NOVEL DERIVATIVE OF PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYLSULPHONAMIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH HAS INHIBITION ACTIVITY WITH RESPECT TO RAF-KINASE, CONTAINING CLAIMED COMPOUND AS ACTIVE INGREDIENT | 2011 |
|
RU2550038C2 |
| HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS | 2017 |
|
RU2783160C2 |
| QUINOLINE AND QUINAZOLINE DERIVATIVES WITH AFFINITY TO 5HT-RECEPTORS | 2004 |
|
RU2402533C2 |
| DERIVATIVES OF 5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING | 2001 |
|
RU2273633C9 |
| N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS EFFECTIVE AS MONOAMINE REUPTAKE INHIBITORS | 2006 |
|
RU2574406C2 |
| HETEROCYCLIC COMPOUNDS AND USE THEREOF IN TREATING OR PREVENTING BACTERIAL INFECTIONS | 2016 |
|
RU2741496C2 |
| CYNNAMIDE COMPOUND | 2005 |
|
RU2361872C2 |
